ED
EMBC icon

Exane Derivatives’s Embecta EMBC Stock Holding History

Exane Derivatives’s Portfolio EMBC Stock Details EMBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$354 Buy
+14
New +$403 ﹤0.01% 612

Other funds holding EMBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's EMBC Position: Q2 2022 in Review

Exane Derivatives opened a new position in Embecta (EMBC) in Q2 2022: 14 shares worth $354. The stake represents ﹤0.01% of the portfolio and ranks #612 among its holdings.

482 funds tracked by Wall St. Rank hold EMBC as of Q2 2022.

  • Exane Derivatives held 14 shares of Embecta worth $354 as of Q2 2022.
  • Embecta was a new Exane Derivatives position in Q2 2022.
  • Embecta made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #612 holding.
  • 482 funds tracked by Wall St. Rank held Embecta as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.